Health Condition 1: C00-D49- Neoplasms
Conditions
Interventions
None listed
Sponsors
Tata Memorial Centre
Eligibility
Inclusion criteria
Inclusion criteria: All patients undergoing major surgeries with anticipated or unanticipated massive blood loss will be considered eligible.
Exclusion criteria
Exclusion criteria: -Age less than 18 years. -Patients who are not willing to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| -To audit current practice of massive blood transfusion management in Tata Memorial Hospital. -To evaluate blood transfusion and coagulopathy management during massive blood loss.Timepoint: 1.Preoperative values (if available) -within 2 weeks before surgery. 2.During surgery. 3.Before shifting the patient out of the operation theatre. 4.Immediately after the surgery in the recovery room/ICU. 5.During the hospital stay. | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Additional measures used for reducing blood loss such as tranexamic acid, factor 7a, prothrombin complex concentrate. 2. Use of TEG and / or Coagulation profile for correction of coagulopathy. 3. To evaluate postoperative organ dysfunction. 4. To evaluate duration of ICU and postoperative hospital stay.Timepoint: 1.During surgery. 2.Before shifting the patient out of the operation theatre. 3.Immediately after the surgery in the recovery room/ICU. 4.During the hospital stay. | — |
Countries
India
Contacts
Public ContactDr Vinay Khare
Tata Memorial Hospital
Outcome results
None listed